Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is Paltusotine, an oral selective nonpeptide...
17 insider purchases on record · latest filing 2023-06-09.
Insiders have also filed 181 sale transactions at CRNX.